Dose conversion from recombinant human erythropoietin to darbepoetin alfa: Recommendations from clinical studies: Managing anemia in patients with chronic kidney disease or cancer: development and role of darbepoetin alfa

Dose conversion from recombinant human erythropoietin to darbepoetin alfa: Recommendations from clinical studies Managing anemia in patients with chronic kidney disease or cancer: development and role of darbepoetin alfa

Saved in:
Bibliographic Details
Published in:Pharmacotherapy Vol. 22; no. 9; pp. 160S - 165S
Main Author: SCOTT, Shane D
Format: Journal Article
Language:English
Published: Boston, MA Pharmacotherapy 2002
Subjects:
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Medical sciences
Pharmacology. Drug treatments
Erythropoiesis
Human
Kidney disease
Urinary system disease
Erythropoietin
Anemia
Hemopathy
Malignant tumor
Glycoprotein hormone
Biological activity
Chemotherapy
Treatment
Hemoglobin
Complication
Clinical trial
Hematocrite
Recombinant protein
Pharmacokinetics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0277-0008
1875-9114